Add to ORKGA small proportion of HIV-infected individuals generate a neutralizing antibody (NAb) response of excep-tional magnitude and breadth. A detailed analysis of the critical epitopes targeted by broadly neutralizing antibodies should help to define optimal targets for vaccine design. HIV-1-infected subjects with potent cross-reactive serum neutralizing antibodies were identified by assaying sera from 308 subjects against a multiclade panel of 12 “tier 2 ” viruses (4 each of subtypes A, B, and C). Various neutralizing epitop
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
Broadly neutralizing antibodies (bnAbs) are thought to be a critical component of a protective HIV v...
<div><p>Broadly neutralizing antibodies (bnAbs) are thought to be a critical component of a protecti...
A small proportion of HIV-infected individuals generate a neutralizing antibody (NAb) response of ex...
A small proportion of HIV-infected individuals generate a neutralizing antibody (NAb) response of ex...
Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals,...
Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals,...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
Broadly neutralizing antibodies (bNAbs) have remarkable breadth and potency against most HIV-1 subty...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
Identification of broadly neutralizing antibodies (NAbs) generated during the course of HIV-1 infect...
AbstractNeutralizing antibody (nAb) response is sporadic and has limited potency and breadth during ...
Identification of broadly neutralizing antibodies (NAbs) generated during the course of HIV-1 infect...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
Broadly neutralizing antibodies (bnAbs) are thought to be a critical component of a protective HIV v...
<div><p>Broadly neutralizing antibodies (bnAbs) are thought to be a critical component of a protecti...
A small proportion of HIV-infected individuals generate a neutralizing antibody (NAb) response of ex...
A small proportion of HIV-infected individuals generate a neutralizing antibody (NAb) response of ex...
Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals,...
Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals,...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
Broadly neutralizing antibodies (bNAbs) have remarkable breadth and potency against most HIV-1 subty...
Broadly neutralizing antibodies (bNAbs) are rarely elicited by current human immunodeficiency virus ...
Identification of broadly neutralizing antibodies (NAbs) generated during the course of HIV-1 infect...
AbstractNeutralizing antibody (nAb) response is sporadic and has limited potency and breadth during ...
Identification of broadly neutralizing antibodies (NAbs) generated during the course of HIV-1 infect...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
Broadly neutralizing antibodies (bnAbs) are thought to be a critical component of a protective HIV v...
<div><p>Broadly neutralizing antibodies (bnAbs) are thought to be a critical component of a protecti...